ACAMPROSATEACAMPROSATE
EUE-1
ACAMPROSATEACAMPROSATE
Outcome Predicators for Rate of Cumulative Abstinence Duration from Individual Patient Data across 16 European and U.S. Double-Blind Placebo-Controlled Trials (N=4457)
Outcome Predicators for Rate of Cumulative Abstinence Duration from Individual Patient Data across 16 European and U.S. Double-Blind Placebo-Controlled Trials (N=4457)
A universal model of predictors of outcome was shown to fit all studies
– abstinence at the onset of treatment
– medication compliance, both initial and continued
– moderate baseline alcohol dependence severity
– living with a partner and child
There was no significant interaction between treatment and whether the study was US or European
A universal model of predictors of outcome was shown to fit all studies
– abstinence at the onset of treatment
– medication compliance, both initial and continued
– moderate baseline alcohol dependence severity
– living with a partner and child
There was no significant interaction between treatment and whether the study was US or European